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Viruses interact extensively with the host molecular machinery, but the underly-
ing mechanisms are poorly understood. Bacteriophage T7 recruits the small pro-
tein thioredoxin of the Escherichia coli host as an essential processivity factor for
the viral DNA polymerase. We challenged the phage to propagate in a host in
which thioredoxin had been extensively modified to hamper its recruitment.
The virus adapted to the engineered host without losing the capability to propa-
gate in the original host, but no genetic mutations were fixed in the thioredoxin
binding domain of the viral DNA polymerase. Virus adaptation correlated with
mutations in the viral RNA polymerase, supporting that promiscuous thioredoxin
recruitmentwas enabled by phenotypicmutations caused by transcription errors.
These results point to a mechanism of virus adaptation that may play a role in
cross-species transmission.We propose that phenotypicmutationsmay generally
contribute to the capability of viruses to evade antiviral strategies.
INTRODUCTION
Viruses repurpose the host molecular machinery for their own proliferation, block or evade antiviral factors,
and recruit host proteins (proviral factors) for processes critical for virus propagation. Viruses occasionally
jump between species, sometimes with fatal consequences for the new host. Homolog proteins that carry
out the same tasks in two different organisms likely share functionality and 3D-structure but differ in amino
acid sequence, and, consequently, they also differ in the chemical composition of their exposed surfaces
available for intermolecular interaction. In view of this, cross-species transmission is quite remarkable, as it
implies that the virus can simultaneously establish extensive and effective interactions in the two quite
different molecular environments of the new and the old hosts. To explore fundamental mechanisms
behind this molecular-level promiscuity, we have carried out laboratory evolution experiments in which a
lytic phage is challenged to propagate in an engineered host that had been modified to hinder the recruit-
ment of a known proviral factor. Our experiments target a specific virus-host interaction for which extensive
functional and structural information is available, thus considerably facilitating the interpretation of the
experimental results. Indeed, although we observe quick and efficient evolutionary adaptation of the virus
to the engineered host, DNA sequencing reveals that no inheritable, genetic mutations occur at the tar-
geted virus-host interaction. This essentially leaves phenotypic mutations caused by transcription errors
as the only possible mechanism of adaptation in this case, a scenario that is actually consistent with the
mutational pattern we find in the viral RNA polymerase.
Mistakes in protein synthesis, due to translation and transcription errors, are common and lead to the so-
called phenotypic mutations (Drummond and Wilke, 2009; Goldsmith and Tawfik, 2009). Translation error
rates are generally higher than transcription error rates. Yet, transcription errors may have a stronger
impact at the protein level, because an mRNA molecule is typically translated many times (Traverse and
Ochman, 2016). Regardless of their origin, phenotypic mutations are not inherited and are often regarded
as a burden to the organism because they may result in a substantial amount of misfolded protein mole-
cules that are non-functional and that may actually be harmful (Drummond and Wilke, 2009; Goldsmith
and Tawfik, 2009). On the other hand, some phenotypic mutations could provide crucial functional advan-
tages under certain conditions. It has been theorized that phenotypic mutations may play an evolutionary
role by allowing organism survival until functionally useful mutations appear at the genetic level (White-
head et al., 2008; Petrovic et al., 2018). The laboratory evolution experiments reported here support this
hypothesis while providing evidence for a hitherto unknown mechanism of virus adaptation.iScience 24, 102257, April 23, 2021 ª 2021 The Author(s).





Figure 1. 3D structures of the main molecular players in this work
(A) Structure of the viral DNA polymerase interacting with its processivity factor, E. coli thioredoxin (PDB ID 1T8E). The
thioredoxin-binding domain of the viral polymerase is labeled with TBD.
(B) Structures of E. coli thioredoxin (PDB ID 2TRX) and the alternative LPBCA thioredoxin (PDB ID 2YJ7) used in this work.
The amino acid residues that differ between the two structures are shown in stick representation.




ArticleMore generally, we argue here that an adaptation mechanism based on phenotypic mutations has impor-
tant implications beyond the specific model system used here to demonstrate it. Many key intermolecular
interactions may need to occur only a few times per host cell to allow virus propagation and can, therefore,
be realized by mutant proteins present at very low levels. It follows that diversity at the phenotypic level
caused by transcription errors may generate an extensive capability to establish/avoid interactions in
different molecular environments, thus facilitating cross-species transmission and potentially contributing
to the capability of viruses to evade antiviral strategies.RESULTS
Design of the engineered host
Bacteriophage T7 recruits the small (110 residues) protein thioredoxin from the Escherichia coli host to be
a part of its four-protein replisome (Hamdan and Richardson, 2009). Upon recruitment, thioredoxin be-
comes an essential processivity factor for the viral DNA polymerase (Etson et al., 2010) (Figure 1A). In
the absence of thioredoxin, the processivity of the DNA polymerase is only 1–15 nucleotides per binding
event (versus several hundred upon thioredoxin binding), a very low level that does not lead to virus repli-
cation and propagation in the knockout strains used in this work (see below). Binding of Escherichia coli
thioredoxin to the viral DNA polymerase is mediated by the interaction with a unique 76-residue fragment
often referred to as the thioredoxin-binding domain or TBD (Hamdan and Richardson, 2009; Akabayov
et al., 2010; Lee and Richardson, 2011). This interaction is extremely tight (dissociation constant 5
nanomolar), showing that the TBD has evolved to specifically bind the host thioredoxin (Hamdan and Ri-
chardson, 2009). It follows that replacing E. coli thioredoxin with an alternative thioredoxin could hinder
recruitment and potentially prevent phage propagation in E. coli (Delgado et al., 2017). A simple way to
perform such replacement involves complementing a knockout E. coli Trx– strain with a plasmid bearing
the alternative thioredoxin gene (Delgado et al., 2017). The engineered host used in the experiments re-
ported here is further modified to allow phenotypic mutations linked to viral transcription errors to occur
in both partners of the targeted DNA polymerase-thioredoxin interaction. That is, the DNA polymerase is
transcribed by the viral T7 RNA polymerase, and, in addition, we placed the alternative thioredoxin gene in
the plasmid under a promoter of the viral RNA polymerase. The gene for the wild-type T7 RNA polymerase
was inserted in the host chromosome, which ensures the presence of a significant amount of thioredoxin
even before phage infection. In order to have available a suitable control host, the same procedure was
performed with an E. coli Trx– complemented with a plasmid bearing the gene of E. coli thioredoxin.
The resulting strain is similar to E. coli in terms of growth and susceptibility to bacteriophage T7 (Delgado
et al., 2017) and has been used as a representation of the original host throughout this work.2 iScience 24, 102257, April 23, 2021


















REPLISOME E. coli VARIANTS
Figure 2. E. coli variants used in this work and their behavior as hosts for phage replication
(A) E. coli thioredoxin is recruited for the T7 bacteriophage replisome as an essential processivity factor for the viral DNA
polymerase. A cartoon representation of the replisome is shown here. See Figure 1 in Hamdan and Richardson (2009) for a
more realistic model.
(B) Differences between the three E. coli variants used in this work are related to thioredoxin. An E. coli trx knockout
strain lacks thioredoxin. A control strain expresses the ‘‘normal’’ E. coli thioredoxin, and it is used as our representation of
the original host. The engineered host expresses the alternative LPBCA thioredoxin, which displays only 57% sequence
identity with E. coli thioredoxin (see Figure 1B).
(C) DNA replication for wild-type T7 bacteriophage requires recruitment of E. coli thioredoxin, and efficient virus
propagation is only observed with the original host.
(D) Results reported in this work show, however, that the virus can evolve to propagate in the engineered host. The
evolved virus does not propagate in the knockout host, but still propagates efficiently in the original host, pointing to a





ArticleAs alternative thioredoxinwe used a protein, LPBCA thioredoxin, previously obtained and characterized in detail
as part of an ancestral reconstruction study (Perez-Jimenez et al., 2011; Ingles-Prieto et al., 2013). Actually, LPBCA
stands for ‘‘last common ancestor of cyanobacterial, deinococcus and thermos groups.’’ LPBCA thioredoxin
shares function and 3D-structurewith E. coli thioredoxin but displays only 57% sequence identity with itsmodern
counterpart. As a result, the amino acid composition of its exposed protein surfaces is substantially altered with
respect to E. coli thioredoxin (Figure 1B), and efficient interaction with the thioredoxin binding domain of the
viral DNA polymerase is not likely to occur (Delgado et al., 2017). The putative ancestral nature of LPBCA thio-
redoxin is, of course, immaterial for this work. The key features of LPBCA thioredoxin in the context of this work
are that (1) it poses an a priori tough challenge to the virus and (2) we know beforehand that mutations enabling
recruitment of the alternative thioredoxinmust be at the TBD-thioredoxin interaction surface. This fact facilitates
considerably the interpretation of the experimental data. Figure 2 shows schematically theE. coli variants used in
this work as well as their main features as hosts for phage replication.
General design of the laboratory evolution experiments
In plaque assays with the E. coli Trx– strain complemented with LPBCA thioredoxin (i.e., our engineered























Figure 3. Initial phage evolution experiments performed in this work
In each evolutionary round, plaque assays with serial dilutions of a phage suspension are performed, and, therefore,
number of plaque-forming units in the suspension can be calculated. At each round, a well-defined plaque from the
highest dilution at which plaques are observed is picked and suspended in buffer to yield the phage suspension used to
start the next round (see main text and transparent methods for further details). This protocol was used in the two long




Articlethey are observed only occasionally (Delgado et al., 2017). It appears then that only a tiny fraction of the
virions in the phage sample (107 or less) can actually propagate in the engineered host. Furthermore,
the propagation is initially inefficient, as judged by the very small size of the plaques they generate (Fig-
ure S1). Here, we have evolved such ‘‘anomalous’’ virions for efficient propagation in the engineered










where V0 is the original virus sample, V1 is a virus sample obtained from the initial propagation in the en-
gineered host (double-line arrow), and the V2, V3, etc. samples result from the R1, R2, etc. evolutionary
rounds, each involving plaque assays for propagation in the engineered host with 10-fold dilutions and pla-
que selection (see transparent methods for details and Figure 3 for a pictorial representation of the evolu-
tion experiments). These assays immediately lead to numbers of virus particles (plaque-forming units or
pfu) that could infect the engineered host. For each plaque selected from the rounds of adaptation to
the engineered host, we also performed plaque assays to determine the number of particles that could
infect the original host.
Evolution experiments reveal promiscuous viral adaptation
We first performed two long evolution experiments consisting of an evolutionary round per day during
several weeks. In these experiments, samples corresponding to a plaque surface of 3 3 3 mm2 were
used to start each next round (except for the V1 sample for which the whole plaque was used, because it
was smaller than 3 3 3 mm2). Both experiments (Figure 4) revealed a fast adaptation of the virus to engi-
neered host, as shown by increases in plaque size and in the numbers of plaque-forming units (see Figure S2
for a representative example of the plaque size increases observed in this work). In fact, the numbers of
plaque-forming units determined using the engineered and the original host became similar to each other
within the first 1–2 rounds and, surprisingly, the two numbers remained similar over many rounds of evolu-
tion. The two experiments were stopped at some point and restarted after about 1 month from plates
stored at 4C. In one case (experiment in lower panel of Figure 4), the protocol was changed after re-start-
ing by eliminating an amplification step (see legend of Figure 4 for details). As expected, these 1-month
breaks are reflected in sudden drops in pfu numbers. Nevertheless, the pfu numbers determined using
the original and the engineered hosts still remained very similar to each other. The congruence between
the two pfu numbers is quite remarkable because we challenged the virus to propagate in the engineered
host, and we did not impose any selective pressure for propagation in the original host. Therefore, the
capability of the evolved virus to propagate in the two hosts cannot be explained by assuming two genet-
ically differentiated virus sub-species in our samples, because the subspecies competent to propagate in
the engineered host would have quickly dominated the virus population in the evolution experiments.
Obviously, whatever the virus adaptation mechanism is, it is intrinsically promiscuous, meaning that each
infective virion can propagate in both hosts.
Virus adaptation and host promiscuity are not explained by genetic mutations
It is important to note that none of the many evolved virus samples studied in this work was found to prop-
agate in the knock-out E. coli Trx– strain that lacks thioredoxins. Therefore, the observed host promiscuity is
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Figure 4. Propagation of bacteriophage T7 in engineered E. coli cells with a modified thioredoxin gene
Number of plaque-forming units (pfu) for virus samples from two laboratory evolution experiments performed as
described in the text. Pfu values determined using the engineered host (red) and the original host (blue) are shown. It is
important to note, however, that only selection for propagation in the engineered host has been applied in these
experiments. Data from control experiments are also shown (black). These control experiments used the original (non-
evolved) phage and the original E. coli host and were carried out concurrently with the evolution experiments.
Experiments were interrupted after a substantial number of rounds and restarted from stored plaques after about a
month and continued for an additional number of rounds. The interruption is apparent from the break in the lines that




Articlethioredoxin. Rather, it must be linked to a capability of the viral DNA polymerase to recruit the thioredoxins
in both the original and the engineered hosts. In order to determine the mutations in the viral DNA poly-
merase gene that could potentially be responsible for the promiscuous recruitment, we carried out 14
‘‘short’’ evolution experiments and we performed PCR followed by Sanger sequencing on samples from
the early rounds (see Figure 5 for a pictorial representation of these evolution experiments). Between 1
and 3 genetic mutations appeared in the DNA polymerase in most experiments (see Figure 6 and also Ta-
ble S1 for details), but none of them occurred in the thioredoxin-binding domain. Interestingly, however,
the 21 positions at which mutations are found (including data from the {A,B,C} experiments discussed
below) define a clear structural pattern (Figure 6), clustering in the region of the polymerase domain close


















Figure 5. Evolution experiments modified to include DNA polymerase sequencing
The protocol described in Figure 3 can be easily modified to include PCR amplification and Sanger sequencing of the
DNA polymerase for each phage suspension. This modified protocol was used in the 14 short evolution experiments that
led to the sequence information on the viral DNA polymerase shown in Figure 6 and Table S1.
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Figure 6. Structure of the viral DNA polymerase showing mutations appearing during phage adaptation to the
engineered host
(A) Mutations found in 14 ‘‘short’’ evolution experiments consisting of 2–3 rounds after PCR and Sanger sequencing of the
DNA polymerase (see main text, Figure 5 and Table S1 for details).
(B) Mutations observed at high frequency (fraction >0.95) in the {A,B,C} set of evolution experiments, as determined from
next-generation sequencing of the viral genome (see Figure 7 and main text for details). The mutations shown are those
determined for the virus samples obtained after the fourth round (V5 samples). See Table S2, Figure 9 below and Figure S3
for the mutations in all viral samples during the evolution experiment.
(C) All sites at which mutations were found are highlighted with spheres in a single DNA polymerase structure. It is visually
apparent that no mutations were found in the thioredoxin-binding domain (TBD).
(D) Plot of normalized number of alternative reads in the genome of virus samples from the several rounds of the {A,B,C}
experiments compared with a control experiment in which the non-evolved phage was allowed to propagate in the
original host. These values support that themutations fixed in the DNA polymerase during the {A,B,C} experiments (panel




Articlemutations found can reasonably explain thioredoxin recruitment in the engineered host and, certainly, they
do not allow efficient replication in the absence of thioredoxin, because the evolved virus does not prop-
agate in the knock-out E. coli Trx– strain. However, it is plausible that these mutations increase replication
errors, thus promoting mutations in other viral proteins that trigger processes that eventually lead to
recruitment. This interpretation is supported by experiments and analyses given further below.6 iScience 24, 102257, April 23, 2021
pfu 
















Figure 7. Evolution experiments modified to include the determination of lysis curves and NGS of the viral
genome
The evolution experiments described in Figure 3 can be easily modified to determine E. coli lysis profiles (turbidity versus
time) for the phage from the suspensions at each evolutionary round (see transparent methods for details). Furthermore,
DNA extraction after lysis allows next-generation sequencing of the viral genome at each evolutionary round (see
transparent methods for details). This modified protocol was used in the {A,B,C} set of evolution experiments that led to




ArticleVirus adaptation probed by lysis profiles
Host promiscuity, as described in the preceding sections, was inferred from the congruence between the
numbers of plaque-forming units determined using the engineered host and the control, ‘‘original’’ host.
The implication is, therefore, that each infective virion particle from the evolved virus sample is capable of
replicating in both hosts. This, however, does not necessarily mean that the efficiency of virus replication is
the same in the two hosts. In order to investigate replication efficiency, we performed three additional evo-
lution experiments using a modified protocol that allows lysis profiles to be determined (see Figure 7 for a
pictorial representation of these experiments). We label these experiments as A, B, and C and collectively
refer to them as to the {A,B,C} set. Briefly, experiments were performed as described earlier, but, in addi-
tion, aliquots of the virus suspension at each round were used to assess lysis in solution with the original
host, the engineered host, and, as a control, with the knockout E. coli Trx– strain.
In the three experiments of the {A,B,C} set, the phage adapted to the engineered host similarly to what was
observed in the previous evolution experiments discussed earlier. Adaptation was thus immediately clear
from the general trend toward increased plaque sizes in the first rounds. It is to be noted, however, that, in
order to maximize the amount of sample for DNA extraction, the largest plaque was fully removed from the
agar plate with the smaller number of plaques to start each next round in the {A,B,C} experiments. This
leads to large increases in the determined pfu numbers over the evolution experiment. Actually, the com-
bined pfu data for the three experiments span 5 orders of magnitude (Figure 8A). Still, there is clear congru-
ence between the pfu values determined using the engineered and the original hosts over this very wide
range, showing again that the mechanism of virus adaptation is intrinsically promiscuous.
Lysis profiles for experiments of the {A,B,C} set reveal that, although infective virions can replicate in the
original and the engineered hosts, they certainly do not do so with the same efficiency, at least in the first
evolutionary rounds. As shown in Figure 8B, lysis times decrease over the evolution rounds reflecting, at
least in part, the increases in viral load associated with the use of full plaques to start rounds. More relevant
is the fact that, initially, lysis times are clearly larger for the engineered host as compared with the original
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Figure 8. Engineered host versus original host adaptation during laboratory virus evolution
Data from the {A,B,C} set of laboratory evolution experiments (see text for details). The three experiments involve
selection for propagation in the engineered host.
(A) Pfu values for virus samples from the evolution experiments determined with the original host versus the values
determined with the engineered host. Note that the values span about 5 orders of magnitude. The line is not a fit but
represents the equality of the two pfu values. Color code identifies the experiment: A (orange), B (blue), C (green).
(B) Lysis plots of absorbance at 600 nm versus time for the virus samples from the three evolution experiments.
Absorbance at 600 nm reflects turbidity and lysis is revealed by an absorbance drop. Profiles determined using the
engineered host (red) and the original host (black) are shown. For both the original host and the engineered host, symbols
identify the virus sample: triangles (V1), circles (V2), squares (V3), down-pointing triangles (V4), diamonds (V5). Lysis was not




Articlethe original host, although to an extent that it is variable. Lysis times for the engineered host always remain
larger in one experiment (labeled A), whereas they eventually become somewhat smaller than the lysis
times for the original host in another experiment (labeled C). As expected, no lysis was observed with
the knockout E. coli Trx– strain that lacks thioredoxin, not even after overnight incubation. Overall, from
the point of view of engineered versus original host replication efficiency, the experiments in Figure 8B
can be ranked C > B > A, with the later virus samples from experiment C being the most efficient at repli-
cating in the engineered host.
Next-generation sequencing studies on virus adaptation to the engineered host
The protocol used for the {A,B,C] experiments allows sequencing of the viral genome at each evolutionary
round (see Figure 7). Thus, DNA was extracted from the lysed engineered host samples and used for Illu-
mina next generation sequencing. Certainly, lysis experiments involve an additional evolution step in so-
lution that can potentially result in additional mutations. Still, as it will be apparent from the discussions
further below, the DNA sequencing information from the lysed samples provides a clear picture of the mo-
lecular mechanism behind viral adaptation.
The Illumina sequencing data for the {A,B,C} set were processed in two ways. First, single nucleotide var-
iants (SNVs) that appeared at high frequency (fraction over the total of readings at the position >0.95) were
determined for all viral genes. These results are shown in Figures 9 and S7 and highlighted in yellow in Ta-
ble S2. Secondly, for genes of particular interest, we considered all SNVs fulfilling the following two criteria:
(1) the fraction of the nucleotide variant at a given position over the total number of readings was 0.01 or
higher; (2) the SNV is observed at least two times. Overall, for both, the DNA polymerase and the RNA po-
lymerase, the selected SNVs define clearly bimodal distributions, including low-frequency SNVs (fraction
over total number of readings between 0.01 and 0.05) and high-frequency SNVs (fraction between 0.95
and 1) with no SNVs at intermediate fractions in most cases (Figures S3 and S4). The numbers of low-fre-
quency SNVs are shown in Figure 10, whereas the mutations themselves are given in Table S2. Note that
most of these low-frequency SNVs appear only transiently, are not enriched, and do not become fixed.
On the other hand, for most of the mutations that do become fixed (see files highlighted in yellow in Table

































































































































































Figure 9. Sequence changes in the viral genome during laboratory evolution
Number of high-frequency (fraction>0.95) mutations for the different viral genes during the evolution experiments of the
{A,B,C} set. For the sake of clarity, mutations in class III genes are not shown here, but can be found in Figure S7. The viral
DNA and RNA polymerases have been highlighted. For all other mutations, the gene is indicated within brackets. Data
were obtained by Illumina sequencing of the DNA extracted after lysing of the engineered host samples (see main text
and Figure 7 for details). A control experiment in which the non-evolved virus propagates in the original host yielded no




ArticleSeveral inferences can bemade from these sequencind studies and anlyses: (1) The results obtained for the
DNA polymerase are consistent with those derived using Sanger sequencing discussed earlier. That is, the
fewmutations observed at high frequency do not appear in the TBD (Figure 6B) and cannot directly explain
promiscuous thioredoxin recruitment. Certainly, SNVs at low frequencies occasionally occur in the TBD.
However, they do so transitorily (see Table S2 for details), whereas any genetic mutation that directly
enabled recruitment in the engineered host would have been enriched by selection. Also, no mutations
are fixed in the helicase-primase (product of gene gp4), which interacts with the DNA polymerase in the
replisome. Certainly, one mutation is fixed in gp2.5 during experiment C (Figure 9), but the role of this pro-
tein in the replisome is to coat the ssDNA in the lagging strand (Hamdan and Richardson, 2009). Therefore,
mutations in gp2.5 cannot reasonably explain promiscuous thioredoxin recruitment by the DNA
polymerase.
(2) The mutations in the viral DNA polymerase increase replication errors. This is easily inferred from the
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Figure 10. Number of low-frequency SNVs during virus adaptation to the engineered host
The numbers shown for the viral DNA and RNA polymerases were obtained from the next-generation sequencing of the
viral genome from the virus samples (V1–V5) at the several evolutionary rounds of the {A,B,C} set of experiments. Only
total numbers of low-frequency SNV’s are shown here; see Table S2 for more detailed information. For comparison, we
also include values in a control experiment in which the non-evolved phage was allowed to propagate in the original host.
For the sake of clarity, the bar for the RNA polymerase from the V2 sample in experiment B has been truncated (the actual




Articleas compared with a control experiment in which the non-evolved virus propagates in the control host (note
that we exclude high-frequency SNVs from this analysis, because their accumulation could potentially be
the result of natural selection fixingmutations with a selective advantage). In fact, the pattern of much lower
numbers of SNVs in the control experiments is already apparent for the DNA polymerase and RNA poly-
merase in Figure 10 (see also Figures S3 and S4), and it is not an artifact related to a lower number of read-
ings in the control, as it is visually apparent in Figure S5. This result is confirmed by amore thorough analysis
of the whole viral genome, as described in the following section.
We selected SNVs in the whole viral genome with frequency less than 0.2 as given by the ratio of the number
of nucleotides detected as an alternative to the number of nucleotides identical to those in the reference
genome in the same genomic position. To exclude variants with very low frequencies that may be due to
sequencing errors, only those with a frequency greater than 0.01 were taken into account. Furthermore, to
eliminate the possible noise of mutation hotspots outside the coding regions, as intergenic regions, only
variants coded within the 60 genes of the virus were included. Before comparing the numbers of SNVs from
different virus samples, they were normalized through division by the total number of positions read in each
sample, that is, by a value that corresponds to the sample coverage (average number of reads per nucle-
otide) times the size of the genome. The resulting numbers of normalized alternative reads are shown in
Figure 6D for the several virus samples of the {A,B,C} experiments, together with the values for a control
experiment in which the non-evolved virus propagates in the original host. Lower numbers are obtained
for the control as compared with any of the {A,B,C} experiments, a result which is statistically significant
as supported by T Test p values of 8 3 104 (samples from experiment A), 102 (samples from experiment
B), and 1.5 3 103 (samples form experiment C).
(3) Virus adaptation to the engineered host correlates with mutations in the gene for the viral RNA polymer-
ase. First, large numbers of SNVs, at both high and low frequencies, are determined for the RNA polymer-
ase in samples from the {A,B,C} experiments, whereas very few SNVs are found in the control experiment
using the original virus in the original host (Figures 9, 10 and S4). Again, the low number of SNVs in the con-
trol is not an artifact due to an insufficient number of readings (Figure S5). Secondly, the C > B > A engi-
neered versus original host adaptation pattern (Figure 8B) correlates with the number of high-frequency
mutations observed in the gene for viral RNA polymerase. In particular, the largest number of high-fre-




Articleadaptation to the engineered host is observed (Figure 8B). Certainly, experiment C also shows increased
number of mutations in class III genes (Figures S6 and S7), but these are involved in virion assembly and
host lysis and cannot be connected with replisome assembly in any reasonable way. On the other hand,
as we elaborate later (see Discussion), mutations in the RNA polymerase provide a straightforward expla-
nation for the observed virus adaptation, as they may have an effect on replisome assembly linked to the
possibility of transcription errors (see Discussion for details).Assessing the error levels of viral RNA polymerases
We hypothesize (see Discussion for details) that transcription errors play a key role in the virus adaptation
reported in this work. We deemed convenient, therefore, to qualitatively test the error level of the RNA po-
lymerase from the last round of experiment C using a known procedure (Goldsmith and Tawfik, 2009) based
on the determination of antibiotic resistance. This experiment is briefly described in the following section.
We complemented a JM109 E. coli strain with two plasmids, one bearing the viral RNA polymerase gene
under the promotor of the E. coli RNApolymerase and another one bearing the gene of TEM-1 b-lactamase
under the promotor of the viral RNA polymerase gene. Expression of the viral RNA polymerase is induced
by arabinose, and that of b-lactamase is induced by IPTG. b-lactamase degrades b-lactam antibiotics, and,
in principle, its expression would make E. coli resistant to ampicillin. However, in the cells we are using for
these experiments, the b-lactamase gene is transcribed by the viral RNA polymerase, and, therefore, anti-
biotic resistance will be compromised to some extent by the error-prone nature of the RNA polymerase, as
a substantial number of the phenotypic mutations caused by transcription errors will be disruptive and
compromise the proper folding of b-lactamase to yield an active enzyme (Goldsmith and Tawfik, 2009).
We performed experiments in which cell growth was monitored in solution upon 2-fold serial dilutions
of ampicillin and determined values of inhibitory ampicillin concentration (IC: maximum ampicillin concen-
tration at which growth is observed) for both wild-type T7 RNA polymerase and the variant with the 5 non-
silent mutations from the last round of experiment C (Figure 11). In the absence of arabinose induction, the
viral RNA polymerase is not synthesized, the b-lactamase gene is not transcribed, and, therefore, the IC
value is very low and essentially identical to the value obtained using E. coli cells not-complemented
with the plasmid bearing the b-lactamase gene. Upon arabinose (and IPTG) induction, RNA polymerase
is synthesized, the b-lactamase gene is transcribed, and substantial resistance to ampicillin emerges. How-
ever, the IC values are about 16-fold higher with the wild-type viral RNA polymerase as compared with the
variant from evolution experiment C. This supports that the mutations fixed in the viral RNA polymerase
during evolution experiment C do increase its transcription error rate. Interestingly, western blotting anal-
ysis (Figures 11B) suggest a somewhat higher expression level for b-lactamase when it is transcribed by
RNA polymerase from the evolved virus. One possibility then is that the mutations accumulated in the viral
RNA polymerase during experiment C bring about a transcription process that is both faster and more er-
ror-prone.DISCUSSION
Key results from our phage evolution experiments
We challenged bacteriophage T7 to propagate in a host that had been modified to hinder the recruitment
of a protein that is essential for the assembly of a functional viral replisome. The modification targets a very
specific virus-host interaction involving thioredoxin (a proviral factor) and the thioredoxin binding domain
(TBD) of the viral DNA polymerase. Our laboratory evolution experiments yield some surprising results.
First, the virus adapted to the engineered host (i.e., it evolved to exploit the modified proviral factor)
without losing its competence to propagate in the original host (i.e., it retained the capability to recruit
the unmodified proviral factor). Secondly, genetic mutations cannot explain the observed adaptation.
This is, of course, shown by the fact that no genetic mutations were found in the TBD domain, but it is
also apparent from the observed pattern of promiscuity. Because the interaction between thioredoxin
and the TBD domain of the DNA polymerase is highly specific, genetic mutations that could enable the
recruitment of the modified proviral factor would likely impair the recruitment of E. coli thioredoxin,
causing a strong trade-off, which is not observed in our evolution experiments.Comparison with previous reports of promiscuity in virus adaptation
It is interesting to compare our results with those recently obtained by Petrie et al. (2018) in a laboratory
evolution study on the adaptation of bacteriophage l to a new receptor. Promiscuity (here the capabilityiScience 24, 102257, April 23, 2021 11
Figure 11. Assessment of the error level of viral RNA polymerases
(A) 3D-structure of the viral RNA polymerase showing the positions at which non-silent mutations were fixed during
evolution experiment C (see text and Figure 9 for details).
(B) Western blotting analysis of the expression of the antibiotic resistance enzyme b-lactamase when its gene is
transcribed by viral RNA polymerases, both from the wild-type virus and from the evolved virus from experiment C (see
text and Figure 9 for details). Three independent experiments were run with each RNA polymerase. ‘‘Control’’ refers to
two independent experiments in which the RNA polymerase used (wild type) was not induced and, therefore, the
b-lactamase gene was not transcribed.
(C) Resistance to the antibiotic ampicillin of E. coli strains in which the gene of the antibiotic resistance enzyme
b-lactamase is transcribed by viral RNA polymerases. Values of the inhibitory ampicillin concentration (IC: maximum
ampicillin concentration at which growth is observed) are given for independent experiments starting with different
clones from two transformations. IC values (mg/mL) are very low when the RNA polymerases are not induced (no arabinose
added), and the gene of the b-lactamase is not transcribed. Upon induction of the polymerases, antibiotic resistance is
observed, but lower IC values observed with the RNA polymerase from the evolved virus (from experiment C) support an




Articleto exploit both the new and the old receptors) was also found in this study and attributed to genetic mu-
tations that induced an ensemble of different protein conformations and generated a diversity of interac-
tion capabilities (Petrie et al., 2018). However, it is difficult to see how this mechanism could apply to our
system, because nomutations at the level of DNA are fixed in the TBD domain of the viral DNA polymerase.
Certainly, conformational dynamics is known to be subject to long-distance effects (Petrovic et al., 2018),
and we could consider the possibility that distant mutations in the DNA polymerase caused conformational
diversity in the TBD. Still, we have performed sequence determinations for a substantial number (17) of evo-
lution experiments and have found typically 1–3 mutations per experiment, spreading overall over 21 po-
sitions in the structure of the DNA polymerase (Figure 6D). It would be unrealistic to assume that mutations
at so many different positions show the same capability to trigger, through long-distance effects, the
conformational heterogeneity in the TBD that it is specifically required to enable promiscuous recruitment.
The role of transcription errors on phage adaptation to the engineered host
Once genetic mutations in the DNA polymerase are ruled out as responsible for the observed virus adap-
tation, the only remaining possibility is that mutations at the phenotypic level caused by protein synthesis
errors enable promiscuous thioredoxin recruitment. This possibility is reasonable, because viral replisome
assembly likely needs only occur a few times per host cell to allow virus propagation and can therefore be
mediated by protein variants present at very low level. Phenotypic mutations can be due to translation er-
rors or transcription errors. Because viruses, however, do not encode a translation machinery, the obvious
suspect is the viral RNA polymerase. This enzyme (Cheetham and Steitz, 2000) transcribes the viral genes
involved in virion assembly and host cell lysis (class III genes), as well as those involved in DNA replication
(class II genes), including the gene for the DNA polymerase. Directed evolution studies (Brakmann and
Grzeszik, 2001) indicate that, under the appropriate pressure, the T7 RNA polymerase can evolve toward
increased error rates by accepting mutations in different regions of the molecule. Indeed, our experiments
shown in Figure 11, in which the gene for the antibiotic resistance enzyme b-lactamase gene is transcribed
by the RNA polymerase, support that the mutations fixed in the viral RNA polymerase during evolution
experiment C do increase its error rate. Overall, therefore, mutations in the gene for the viral RNA polymer-
ase could increase transcription error rates and lead to phenotypic mutations, some of which would occur




Articlevariants of the RNA polymerase present at low level (likely the situation of experiment A), although even-
tually selection will lead to fixation of mutations, as it is already observed in experiments B and C (Figure 9).
A mechanism of phage adaptation to the engineered host based on phenotypic mutations
To summarize, our results are consistent with a mechanism of adaptation to the engineered host that in-
volves the following steps: (1) increased replication rates are brought about by mutations in the viral
DNA polymerase; (2) replication errors promote genetic mutations throughout the viral genome including
the gene of the viral RNA polymerase; (3) increased transcription errors cause phenotypic mutations that
enable the interaction between the DNA polymerase and thioredoxin to be established in the engineered
host. This mechanism provides a simple and convincing explanation for the capability of the evolved phage
to propagate in both the original and the engineered hosts. Focusing for illustration on the DNA polymer-
ase, transcription errors will generate a population of molecules with different sets of phenotypic muta-
tions. Some of these molecules will still recruit the original thioredoxin, whereas some other will have
the capability to recruit the alternative LPBCA thioredoxin. Note that the putative ancestral protein we
have used displays higher stability (Perez-Jimenez et al., 2011) and better folding kinetics properties (Ga-
miz-Arco et al., 2019) than its modern E. coli counterpart, which should contribute to somewhat higher
levels of folded protein in vivo. This explains that lysis times for the engineered host eventually become
somewhat smaller than the lysis times for the original host in experiment C (Figure 8B).
Of course, it may seem at first surprising that, according to our proposed mechanism, phenotypic muta-
tions enable virus replication in the engineered host while they compromise antibiotic resistance in the
experiment described in Figures 11C in which the gene for the antibiotic resistance enzyme b-lactamase
gene is transcribed by the RNA polymerase from the evolved virus. However, it is important to note that
the required numbers of functional enzymes greatly differ between the two scenarios. Antibiotic resistance
requires a substantial amount of active b-lactamase and will therefore be compromised by phenotypic
mutations which, in most cases, impair proper folding to yield an active enzyme. On the other hand, virus
infection of a cell typically results in the generation of a comparatively small number of virions, and
replication, therefore, could be achieved on the basis of just a few efficient replisomes. In this scenario,
phenotypic mutations could certainly lead to misfolded proteins but also to a small, but sufficient, number
of variants capable to form efficient replisomes and enable replication.
General implications of this work
The experimental studies reported here make use of a host that has been engineered to display a very spe-
cific difference with the original host and also to promote phenotypic mutations at the targeted host-virus
interaction. Still, we argue that phenotypic mutations caused by transcription errors may provide a general
mechanism for virus adaptation. Virus infection of a cell typically results in the generation of a not too large
number of new virions. It follows that many of the key intermolecular interactions involved in virus infection
and replication need only occur a few times per host cell and could be mediated by very low levels of pro-
tein variants with enabling phenotypic mutations. To illustrate the plausible generality of the proposed
adaptation mechanism, several potential examples are briefly discussed later.
Virus cross-species transmission requires that the virus has the remarkable capacity to establish key inter-
actions in the two different molecular environments of the old and the new host. Diversity at the phenotypic
level caused by transcription errors may generate an extensive capability to establish/avoid interactions in
different molecular environments, thus facilitating cross-species transmission. The adaptation mechanism
based on phenotypic mutations may be immediately implemented in RNA viruses in which both replication
and transcription are performed by error-prone RNA-dependent RNA polymerases. For instance, RNA syn-
thesis in coronaviruses produces, not only genomic RNA but also subgenomic RNAs that are not encapsu-
lated in the assembled virions but that function as mRNAs for downstream genes (Fehr and Perlman, 2015;
de Wilde et al., 2018), potentially leading to ‘‘useful’’ (for the virus) phenotypic diversity in other structural
proteins including the spike (of which there are many copies in the virion surface). Furthermore, transcrip-
tion errors may conceivably lead to viral protein variants capable of evading antiviral strategies. Phenotypic
mutations might, for instance, allow the evasion of antibody neutralization, a phenomenon that plausibly
contributes, for instance, to the so-called influenza puzzle (Ellebedy and Ahmed, 2016), i.e., the fact that
influenza remains a health problem despite repeated exposure of the population worldwide to natural
infection and to influenza viral proteins through vaccination. Another intriguing possibility is that pheno-




Articleantivirals (Pennings, 2012; Irwin et al., 2016) by complementing the effect of the few mutations that appear
at the genetic level. Obviously, these suggested possibilities rely on the notion that protein variants with
suitable phenotypic mutations and present at very low concentrations may enable key processes for virus
infection and replication. The interest in determining low-level mutations in viral mRNAs thus emerges. This
task is compromised by normal errors of next-generation sequencing and the errors introduced in reverse
transcription steps. Still, methods to circumvent these problems have been developed in recent years (Lu
et al., 2020).Limitations of the study
We propose that phenotypic mutations play a role in phage adaptation to the engineered host mainly
because we find the obvious alternative explanations to be highly unlikely or impossible in the light of
the reported experimental results. The proposal is certainly supported by the mutational pattern we find
for the viral RNA polymerase. Yet, the molecular mechanisms of virus replication are not fully understood.
Therefore, we cannot be absolutely certain that our analyses have ruled out all possible explanations that
rely upon a role for genetic mutations. Consequently, it is conceivable (although we do not think it is likely)
that our proposal is an instance of the so-called Holmesian fallacy. Work currently in progress in our labo-
ratory aims at deriving more direct evidence for the role of phenotypic mutations in virus adaptation.Resource availability
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Fig S1. Pictures of representative plaques corresponding to the initial infection of 
the engineered E. coli strain that contains the alternative LPBCA thioredoxin (the 










EXPERIMENT 2 (SANGER) 
 
Fig. S2. Pictures showing a representative increase in the size of plaques along the 
evolution experiment in which the virus adapted to an engineered host containing 










Fig. S3. Sequence changes in the viral DNA polymerase during laboratory virus 
evolution. Related to Figures 7, 8, 9 and 10. Single nucleotide variants (SNVs) for the 
gene of the viral DNA polymerase for virus samples from the three evolution 
experiments of Figure 8. Data were obtained by Illumina sequencing of the DNA 
extracted after lysis of the engineered host samples. Mutations are binned according to 
its frequency and the plots show the number of mutations for each 0.05 bin. The 
mutations that are “fixed” (fraction of occurrence between 0.95 and 1) have been 
identified. One silent mutation is included because, perhaps, it cannot be ruled out that it 
could have some effect at the level of RNA structure that translates into some effects on 
the structure resulting from cotranslational folding. Data for a control experiment 
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Fig. S4. Sequence changes in the viral RNA polymerase during laboratory virus 
evolution. Related to Figures 7, 8, 9 and 10. Single nucleotide variants (SNVs) for the 
gene of the viral RNA polymerase for virus samples from the three evolution 
experiments of Figure 8. Data were obtained by Illumina sequencing of the DNA 
extracted after lysis of the engineered host samples. Mutations are binned according to 
its frequency and the plots show the number of mutations for each 0.05 bin. The 
mutations that are “fixed” (fraction of occurrence between 0.95 and 1) have been 
identified. Data for a control experiment corresponding to the propagation of the 
original virus in the original E. coli host is also included. 
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Fig. S5 Total number of readings for the genes of the viral RNA (A) and DNA (B) 
polymerases determined from Illumina sequencing of samples from the different 
rounds of the evolution experiment of the {A,B,C} set. Related to Figures 8, 9 and 
10. Data for control experiments mimicking the evolution experiment but using the 
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Fig. S6. Sequence changes in the viral genome during laboratory evolution. 
Related to Figures 8 and 9. A, Number of high frequency (fraction>0.95) mutations 
for the different viral genes during the evolution experiments of the {A,B,C} set. The 
viral DNA and RNA polymerases have been highlighted. Data were obtained by 
Illumina sequencing of the DNA extracted after lysing of the engineered host samples. 
B, Same as in A, but for a control experiment in which the non-evolved phage 
propagates in the original host. Black is used here to highlight that this is a control 
experiment. A panel with lysis curves for this control is included. No selection for 
propagation in the engineered host is applied in this control experiment and the phage 
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Fig. S7. Sequence changes in the viral genome during laboratory evolution. 
Related to Figure 7 and 9. Number of high frequency (fraction>0.95) mutations for the 
different viral genes during the evolution experiments of the {A,B,C} set. Only 
mutations in class III genes are shown here. See Figure 9 in the main text for mutations 
in class I and class II genes. Data were obtained by Illumina sequencing of the DNA 
extracted after lysing of the engineered host samples (see main text and Figure 7 for 
details). A control experiment in which the non-evolved virus propagates in the original 




























































































































































































































Table S1. Mutations in the viral DNA polymerase determined from PCR and 
Sanger sequencing on samples from the early rounds of 14 evolution experiments. 
Related to Figures 5 and 6. 
 
Experiment POS NT_CHANGE AA_CHANGE V1 V2 V3 
1 15533 1181A>G Lys394Arg X X ND 
2 14473 121G>T Ala41Ser X ND X 
2 15652 1300T>C Phe434Leu - ND X 
3 14398 46A>G Thr16Ala X ND X 
4 14485 133G>A Ala45Thr X ND X 
5 14463 111T>C Ser37Ser X ND X 
6 14382 30C>T Ala10Ala X ND X 
6 15445 1093G>A Asp365Asn - ND X 
6 15578 1226A>G Tyr409Cys - ND X 
7 14434 82A>G Thr28Ala X ND X 
8 14495 143C>T Ala48Val X X ND 
8 15512 1160A>G Lys387Arg X X ND 
9 14485 133G>A Ala45Thr X X ND 
9 15512 1160A>G Lys387Arg X X ND 
10 14434 82A>G Thr28Ala X - ND 
11 14359 7G>A Val3Ile X X ND 
11 15533 1181A>G Lys394Arg X X ND 
12 14412 60C>T Cys20Cys X X ND 
12 15380 1028A>G Gln343Arg X X ND 
13 14494 142G>A Ala48Thr X X ND 
13 15512 1160A>G Lys387Arg X X ND 
14 14463 111T>C Ser37Ser X X ND 








Strains used in this work 
We use as the original host the E. coli strain DHB4 (Delgado et al., 2017). The 
engineered host is based upon a receptor strain FA41 which is a DHB4 strain deficient 
in the two thioredoxins identified in the cytoplasm of E. coli: thioredoxin 1, which we 
refer throughout the text simply as E. coli thioredoxin and which is the thioredoxin 
recruited by the non-evolved virus for its replisome, and thioredoxin 2, which is induced 
under some stress conditions and has an additional zinc-binding domain. This DHB4 
trxA trxC strain was a gift from Jon Beckwith (Harvard Medical School). We further 
performed the curation of the F’ factor (which would prevent phage infection) and 
lysogenization (using the lDE3 Lysogenization kit from Novagen) to introduce in the 
bacterial chromosome the gene of the T7 RNA polymerase (Delgado et al., 2017). This 
results in the E. coli Trx– strain that has been used as a control throughout this work. 
The gene for LPBCA thioredoxin was cloned in pET30a(+) under a T7 RNA 
polymerase promoter (Delgado et al. 2017). This system is leaky and leads to a basal 
expression level, even under non-inducing conditions. Complementation of the E. coli 
Trx– strain with this plasmid produced the engineered host extensively studied in this 
work. The gene for E. coli thioredoxin was also cloned in pET30a(+) and 
complementation of the E. coli Trx– strain with this plasmid produced the version of the 
original host used in this work. 
 
Plaque assays 
Plaque assays were performed as follows (Delgado et al., 2017). Briefly, phage 
samples were serially diluted in Tris buffer 20 mM pH 7.4 (including 100 mM NaCl, 10 
mM MgSO4). Strains were grown to an absorbance of ~0.5 in LB medium at 37 ºC and 
100 µL of the cell suspension were mixed with 100 µL of a phage suspension and the 
resulting mix was combined with 4 mL of molten agar. Plates were incubated at 37 ºC 
overnight or 15 hours for the experiments A, B and C (Fig. 3). Numbers of plaques were 
determined from visual inspection and counting. Phage titer was calculated upon serial 
dilution experiments from the number of plaques at the two highest phage dilutions at 
which plaques are observed. 
 
Lysis experiments and DNA extraction 
Lysis experiments were carried out using a straightforward modification of the 
protocol we previously used for the determination of generation times (Delgado et al., 
2017). Briefly, preinocula in LB were incubated overnight at 37 ºC. Cultures were then 
diluted 1/200 in fresh medium and the absorbance at 600 nm was determined as 
function of time for about 4 hours typically while keeping the temperature at 37 ºC. A 
volume of virus sample was added when the absorbance was 0.25-0.3. After lysis, 
cultures were collected and kept at -20 ºC until DNA extraction. For this, samples were 
thawed on ice, mixed with 1/60 chloroform, vortexed and centrifuged at 4000g for 10 
minutes.  DNA was isolated from the supernatant using the phage DNA isolation kit 
from Norgen (CAT#46800). 
 
Evolution experiments 
 The evolution experiments were initiated by a standard plaque assay in which 
the host engineered strain was infected with an appropriate dilution of wild type phage 
suspension. Initially, after overnight incubation a clearly well-isolated large plaque was 
  
picked up from the agar plate and transferred to a 1 mL of buffer (Tris buffer 20 mM 
pH 7.4, 100 mM NaCl, 10 mM MgSO4). Virus particles were allowed to diffuse for 2 
hours and titration of the phage suspension was performed. Subsequently, one 100 μl 
aliquot was used to start the next round of evolution by infection of a fresh culture of 
the engineered host. An additional amplification step (Delgado et al., 2017) was 
included in the rounds before the one-month break in the experiment shown in the lower 
panel of Figure 4.  
 
Genomic DNA sequencing 
 gDNA samples from ~50 isolates of bacteriophage T7 were extracted with the 
phage isolation kit from Norgen (CAT#46800) and quantified using a Nanodrop One 
(ThermoFisher). Subsequently, gDNA was purified using MucleoMag Beads (Omega) 
without size selection. The quality of the gDNA was evaluated by Qubit dsDNA HS 
Assay kit (ThermoFisher) and 0.8% agarose gel electrophoresis. 37 libraries were 
constructed with an input of 100-300 ng of DNA using the NexteraTM DNA Flex 
Library Preparation kit with only 5 PCR cycles in the indexing step. The quality of the 
libraries was validated by the Qubit dsDNA HS Assay kit (ThermoFisher) with a 2100 
Bioanalyzer (Agilent Technologies). Libraries were sequenced on an Illumina MiSeq 
producing 1170569 of 2x250 bp read, i.e., 61762 average reads per sample, reaching an 
average coverage of 369x. 
 
 Initially, the sequences for each isolate were subjected to quality evaluation 
using FASTQC software, which provides an extensive report of the quality of the reads 
(Andrews, 2010). On the basis of the generated report, we determined a very high drip 
in the quality value of the last sequenced nucleotide, which was, therefore, eliminated. 
We also verified that the amount of Ns and adapters included in the sequences was 
almost negligible. The average quality of all reads was above 30. After this quality 
filter, we called and annotated all variants on the basis of the following steps performed 
by Snippy (Seemann, 2015). Burrow Wheeler Alignment (Li and Durbin, 2009) was 
used to align the reads against the reference genome (GCF_000844825 from 
GeneBank). Samtools (Li and Durbin, 2009) was used to sort, mark and remove 
duplicate sequences. Variant calling was performed by Freebayes (Garrison and Marth, 
2012) using the following parameters: “-P 0 – C 10 –min-repeat-entropy 1.5 –strict-vcf 
–q 15 –m 30” which involves the exclusion of reads having a mapping quality of less 
than 30. Furthermore, alleles were excluded from the analysis if their supporting base 
quality was less than 15. The remaining variants were processed by snpEff (Cingolani et 
al., 2012) to annotate and predict their effects on genes and proteins. The single 
nucleotide variants discussed in the text are the outcome of an additional filtering 
process by bcftools (Danecek and McCarthy, 2017) to eliminate further possible errors. 
Variant determination at a given position required at least 10 sequences including the 
position and a mapping quality of at least 100. Finally, we eliminated all those variants 
that did not have at least 2 reads supporting the alternative nucleotide or that had a 
frequency lower than 0.01 (the frequency is calculated by dividing the number of reads 
that support the alternative by the number of reads whole nucleotide is equal to the 
reference). Raw sequencing data are available in the Sequence Read Archive (SRA) 
under the PRJNA656432 BioProject accession number.  
 
 
Antibiotic-resistance assessment of RNA polymerase error level 
 We used E. coli JM109 competent cells (Agilent), the following plasmids: 
  
 
pACYC -T7 RNAP-wt, encoding the wild type RNA polymerase under lacI repression 
and induced by addition of L-arabinose, pACYC -T7 RNAP-variant, encoding the RNA 
polymerase from the viral V5 sample of experiment C, under lacI repression and 
induced by addition of L-arabinose, pET30a(+)-TEM-1, encoding the TEM-1 b-
lactamase gene under the control of the T7 operon and induced by addition of IPTG, 
and the following media for bacterial growth, LB medium. 10 g/L Bacto -Tryptone, 5 
g/L Bacto -Yeast Extract, 5 g/L NaCl, autoclave to sterilize. Allow the auto-claved 
medium to cool to 55ºC and add chloramphenicol (35 mg/mL), kanamycine (50 
mg/mL) and glucose (1%). For LB plates, 1.5% Bacto-agar (15 g/L) was added prior to 
autoclave. SOC medium. 2% Tryptone (bacto), 0.5% Yeast Extract, 10 mM NaCl, 2.5 
mM MgCl2, 10 mM MgSO4, 20 mM glucose. 
 
Transformation of plasmid DNA into E. coli using the heat shock method was 
performed using well-established protocols. Briefly, after a short incubation in ice (30 
min), a mixture of chemically competent bacteria and DNA is placed at 42°C for 45 
seconds (heat shock) and then placed back in ice. SOC media is added and the 
transformed cells are incubated at 37°C for 1 h with agitation. Cells were plated on LB 
agar plates with chloramphenicol (35 µg/mL), kanamycine (50 µg/mL) and glucose 
(1%) and grown without selection (O/N, 37 °C). Colonies carrying a TEM-1 and T7 
RNAP-wt or TEM-1 and T7 RNAP-variant were picked and individually grown in 5 
mL of “Liquid growth media” [LB medium with chloramphenicol (35 µg/mL), 
kanamycine (50 µg/mL) and glucose (0.2%)] for 16 h at 37 °C with shaking.  
 
To test ampicillin resistance, cultures were diluted 1/100 in fresh ‘‘Liquid 
growth media” and strains were grown to an absorbance of ~0.2 add L-arabinose to be 
concentration final 0.2%, and culture at 37ºC for 5 h. Then, b-lactamase expression was 
induced by addition of 0.5 mM IPTG for 2 h (37 °C, shaking). Finally, after de 
induction the cultures were diluted (1:100) in fresh “Liquid growth media” with IPTG 
0.5 mM and varying concentrations of ampicillin (0, 2, 4, 8, 16, 32, 64,128, 256, 512, 
1024, 2048 µg/mL). Culture were grown overnight at 37 °C and the inhibitory 
concentration for TEM-1 were determined from visual inspection. The inhibitory 
concentration of each transformant, were assayed in duplicate with two independent 
transformations. 
 
To assess the expression levels of TEM-1 b-lactamase when its gene is 
transcribed by the viral RNA polymerases, cultures (prepared as described above) were 
diluted 1/100 in fresh ‘‘Liquid growth media”, the strains were grown to an absorbance 
of ~0.2, L-arabinose to be concentration final 0.2% was added and the cultures were 
grown at 37ºC for 5 h. b-lactamase expression was then induced by addition of 0.5 mM 
IPTG. After 2 hours at 37 °C with shaking, the cultures were diluted (1:100) in fresh 
“Liquid growth media” with IPTG 0.5 mM and grown overnight at 37 °C. 5 ml of 
bacterial cultures were then centrifuged for 10 min at 4000 rpm at 4ºC. Pellets were 
resuspended in 2 ml buffer [10 mM potassium phosphate buffer, pH 6.5, 1 mM EDTA, 
20% (w/v) sucrose, 1 mg ml-1 lysozyme]. Cell lysis was performed by sonication using a 
Vibra cell ultrasonics processor (1 seg. pulse, 60% amplitude, eight cycles) with 
cooling. Equal volumes of cell lysis preps were loaded onto a 15% PAGE-gel. The cell 
lysis preparations were analyzed by Western blotting. Western blots were revealed with 
monoclonal Anti-TEM-1 b-lactamase antibody produced in mouse (Invitrogen  MA1-
  
10712) and Horseradish Peroxidase (HRP)-conjugated goat anti-mouse antibodies 
(Santa Cruz Biotechnology ).  After chemiluminescence (ECL) detection, the membrane 
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